1. What is TB-500?

TB-500 is the synthetic version of a naturally occurring peptide called Thymosin Beta-4 (Tβ4), which is present in almost all human and animal cells. It plays a crucial role in tissue regeneration, wound healing, cell migration, and inflammation modulation. TB-500 is widely studied for its potential in accelerating recovery from injuries, enhancing flexibility, and supporting cardiovascular and muscular health.

2. TB-500 Structure

Molecular Formula:C38H68N10O14

Molecular Weight:889.0g/mol

CAS Number:77591-33-4

3. TB-500 Research

TB500 is a synthetic fragment of the natural thymosin β4 peptide, designed for enhanced bioavailability and systemic tissue distribution. It acts as a master regulator of cell migration, angiogenesis, and tissue remodeling.

1 Molecular Mechanisms

Actin modulation: Binds G-actin, regulating polymerization, and enabling cell migration to damage sites.

Angiogenesis induction: Encourages endothelial movement and new vessel formation, optimizing oxygen and nutrient delivery.

Anti-inflammatory/regenerative signaling: Suppresses pro-inflammatory cytokines and promotes progenitor/stem-cell mobilization, reducing fibrosis【https://pubmed.ncbi.nlm.nih.gov/23050815/】.

Wound matrix restructuring: Enhances collagen deposition and scar resolution in conjunction with MMP signaling【https://pmc.ncbi.nlm.nih.gov/articles/PMC8228050/?utm_source=chatgpt.com】.

Tissue-specific repair: Demonstrates cardiac, corneal, dermal, neural, and diabetic wound-fixing activity in animal models【https://medicalantiaging.com/wp-content/uploads/2024/10/MAA-TB-500-Medical-Evidence.pdf?utm_source=chatgpt.com】.

2 Preclinical & Early Clinical Evidence

Rodent wound healing: Topical or injected TB500 enhanced re-epithelialization by up to 61% and contraction by 11% in 7 days【https://pubmed.ncbi.nlm.nih.gov/10469335/】.

Dermal ulcers (Phase II): TB500 reduced healing time by ~4 weeks in pressure/stasis ulcer patients【https://pmc.ncbi.nlm.nih.gov/articles/PMC8228050/?utm_source=chatgpt.com】.

Dermal, corneal, cardiac repair: Animal studies show improved angiogenesis, scar reduction, and myocardial recovery post-MI【https://pmc.ncbi.nlm.nih.gov/articles/PMC8228050/?utm_source=chatgpt.com】.

Diabetic wound model: TB500 restored healing rates in diabetic and elderly rodents via collagen-enhanced remodeling【https://medicalantiaging.com/wp-content/uploads/2024/10/MAA-TB-500-Medical-Evidence.pdf?utm_source=chatgpt.com】.

Neurological recovery: Rat brain injury models showed oligodendrocyte activation, vessel growth, and improved behavior【https://ai.hubermanlab.com/s/zQidi4We?utm_source=chatgpt.com】.

Why Consider TB500?

Rapid, systemic recovery: Supercharges cell migration and repair across entire body—ideal for multi-site or systemic trauma.

Robust tissue regeneration: Promotes angiogenesis and collagen remodeling in connective tissue, heart, cornea, and brain.

Anti-fibrotic potential: Assists in high-quality healing with minimized scarring.

Synergy with other regeneration peptides: Notably complements BPC157 for enhanced tendon and muscle recovery.

Anti-inflammatory & mitochondrial support: Reduces oxidative stress, fostering quicker inflammatory resolution and cellular energy recovery.

Broad-use therapeutic peptide: Suggested roles in sports recovery, rehabilitation, aesthetics (fat grafting), cardiovascular care, and neurorepair.

 

4. Future TB-500 Research

  • High-quality human clinical trials
    Transition from rodent data to validated randomized controlled trials across wound types, sports injuries, cardiac repair, and corneal healing.
  • Mechanistic and biomarker profiling
    Explore transcriptional impact on angiogenic, matrix remodeling, inflammation, and regenerative pathways.
  • Innovative delivery systems
    Develop targeted sustained-release formulations: hydrogels, microneedles, transdermals, or oral systems.
  • Comparative efficacy studies
    Assess TB500 vs. BPC157, or synergistic co-therapy protocols using rigorously designed head-to-head evaluations.
  • Organ-specific applications
    Explore use in myocardial infarction, corneal repair, diabetic ulcers, anti-fibrotic therapy, and CNS neuroregeneration.
  • Athletic injury and performance recovery
    Clinical protocols tailored for tendon repair, ligament rehabilitation, and post-competition recovery regimens.

5. Application Areas

Scenario Role of TB500
Skin & Wound Healing Speeds re-epithelialization and reduces scar tissue
Soft Tissue Repair (Muscle/Tendon) Boosts collagen, cell migration, flexibility
Ulcers & Diabetic Wounds Enhances collagen deposition and contraction
Post-Surgical Recovery Supports healing after grafts and cosmetic procedures
Cardiac Repair (Post-MI) Promotes vascular repair and reduces damage
Corneal/Refractive Healing Optimizes repair and minimizes apoptosis
Neurological & Ischemic Care Supports vascular and neural regeneration
Sports Therapy & Aesthetics Enhances recovery and performance in athletes

Summary

TB500 is a scientifically promising peptide demonstrating strong preclinical and preliminary clinical evidence for accelerating whole-body repair, angiogenesis, and scar-minimizing remodeling. Its action spans dermal to cardiac and neural tissues, making it broadly applicable in wound care, regenerative wellness, sports recovery, and aesthetic optimization. As advanced trials and formulations emerge, TB500 is poised to become a cornerstone in regenerative peptide therapy.

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATONAL AND EDUCATIONAL PURPOSES ONLY.

 

The products offered on this website are furnished for in-vitro studies only. In-vitro studies(Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

Reviews

There are no reviews yet.

Be the first to review “TB-500 (Thymosin Beta-4) 5mg”

Your email address will not be published. Required fields are marked